Researchers at Children’s Hospital of Philadelphia (CHOP) and the University of Pennsylvania Perelman School of Medicine pioneered a new model that offers a potential platform for developing novel therapies to treat Alpha Thalassemia (AT), a severe blood disorder. The findings were published in the journal Blood.

Results led to expanded FDA approval in January 2024.

Researchers in the Division of Orthopedics and Sports Medicine and Performance Center at Children’s Hospital of Philadelphia (CHOP) announced results from a large retrospective study of patients surgically treated for Patellar Sleeve Fractures (PSFs), rare knee fractures that occur when a piece of bone and cartilage separates from kneecap. They found that in most pediatric patients with displaced fractures, surgery was effective in restoring full range of motion (ROM) and enabled them to return to their regular activities.

Discovery could one day serve as the basis for a non-insulin based therapeutic

Children between 5 and 12 are more likely to experience worse symptoms and delays in specialist care if injured during recreation or other non-sport activities.

While unable to speak, patients can understand parents and caregivers, paving the way for future clinical trial design

Check out CDC’s reports on meningococcus and mpox, a summary of SAGE’s report on global immunization, and an opportunity to obtain continuing education credits.

Written in an approachable and engaging manner, this book offers many thought-provoking ideas about the power of words and how we communicate with each other. Find out more.

Find info and resources about Pemivibart, a long-acting monoclonal antibody against the spike protein of SARS-CoV-2.

Published in JAMA, this review assessed the threat of a global avian influenza outbreak to humans.